[Form 4] Ardent Health, Inc. Insider Trading Activity

Ardent Health, Inc. Chief Operating Officer Dave Caspers received an equity award of 35,673 shares of Common Stock on April 1, 2026 as a grant or award.

Rhea-AI Filing Summary

Ardent Health, Inc. Chief Operating Officer Dave Caspers received an equity award of 35,673 shares of Common Stock on April 1, 2026 as a grant or award. The award represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to his continued service with the company.

On the same date, 2,684 shares were withheld at $8.67 per share to cover tax obligations in accordance with Rule 16b-3, a routine tax-withholding disposition rather than an open-market sale. After these transactions, Caspers directly owned 71,277 shares of Common Stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Caspers Dave

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	2,684	$8.67	$23K
Grant/Award	Common Stock	35,673	$0.00	$0.00

Holdings After Transaction: Common Stock — 71,277 shares (Direct)

Footnotes (3)

1. F1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
2. F2. Represents the closing price of the common stock of the Issuer on April 1, 2026.
3. F3. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

Key Figures

Equity award: 35,673 shares Tax-withheld shares: 2,684 shares Withholding price: $8.67 per share +1 more

4 metrics

Equity award 35,673 shares Common Stock grant to COO on April 1, 2026

Tax-withheld shares 2,684 shares Shares withheld to pay taxes on April 1, 2026

Withholding price $8.67 per share Closing price used for tax withholding on April 1, 2026

Post-transaction holdings 35,604 shares Direct Common Stock owned by COO after transactions

Key Terms

restricted stock units, Rule 16b-3, Chief Operating Officer

3 terms

restricted stock units financial

"Represents restricted stock units that vest in three substantially equal installments"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 16b-3 regulatory

"Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

Chief Operating Officer financial

"Caspers Dave serves as Chief Operating Officer of Ardent Health, Inc."

A chief operating officer (COO) is a senior executive responsible for overseeing the day-to-day activities of a company, ensuring that all parts of the organization work smoothly and efficiently. They often act like a company's operational quarterback, translating strategic plans into practical actions. For investors, the COO's effectiveness can influence a company's performance and stability, making them an important figure in assessing the company's management strength.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARDT COO Dave Caspers report?

Dave Caspers received a 35,673-share Common Stock award from Ardent Health, Inc. on April 1, 2026. This equity grant reflects compensation rather than an open-market purchase and is structured as restricted stock units with multi-year vesting.

How many Ardent Health (ARDT) shares were withheld for taxes?

Ardent Health withheld 2,684 shares from Dave Caspers on April 1, 2026. The shares were used to cover tax obligations tied to the vesting award and were valued at $8.67 per share, the closing stock price that day.

Is the ARDT COO’s tax withholding a stock sale?

The 2,684-share disposition is a tax-withholding transaction, not an open-market sale. Shares were delivered back to the issuer to satisfy taxes triggered by the vesting of restricted stock units under Rule 16b-3.

How many Ardent Health (ARDT) shares does Dave Caspers hold after these transactions?

Following the April 1, 2026 award and tax withholding, Dave Caspers directly owned 35,604 shares of Ardent Health Common Stock. This figure reflects his reported direct holdings immediately after the compensation grant and related tax-share disposition.

How do the ARDT restricted stock units granted to the COO vest?

The 35,673 restricted stock units granted to Dave Caspers vest in three substantially equal installments. Vesting occurs on each anniversary of April 1, 2026, and is conditioned on his continued service with Ardent Health through each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:27 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caspers Dave

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		F		2,684(1)	D	$8.67(2)	35,604	D
Common Stock	04/01/2026		A		35,673(3)	A	$0	71,277	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

2. Represents the closing price of the common stock of the Issuer on April 1, 2026.

3. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)